Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹46 Cr₹-1.95 Cr₹-117 Cr₹-131 Cr₹69 Cr

What is the latest Consolidated Net Profit of ORCHID PHARMA ?

The latest Consolidated Net Profit ratio of ORCHID PHARMA is ₹46 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹46 Cr
Mar2023₹-1.95 Cr
Mar2022₹-117 Cr
Mar2021₹-131 Cr
Mar2020₹69 Cr

How is Consolidated Net Profit of ORCHID PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹46 Cr
Positive
Mar2023 ₹-1.95 Cr
Negative
Mar2022 ₹-117 Cr
Negative
Mar2021 ₹-131 Cr
Negative
Mar2020 ₹69 Cr -

Compare Consolidated Net Profit of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹7,389.5 Cr 3.1% -22.4% 76.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,699.0 Cr 0.6% -4.6% 20.7% Stock Analytics
DIVIS LABORATORIES ₹162,584.0 Cr 9.8% 4.5% 64.7% Stock Analytics
CIPLA ₹116,022.0 Cr -2.9% -3.9% 1.1% Stock Analytics
DR REDDYS LABORATORIES ₹102,463.0 Cr 0.9% -10.4% 0.1% Stock Analytics
ZYDUS LIFESCIENCES ₹98,434.8 Cr 0.9% -0.3% 27.9% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

3.1%

-22.4%

76.6%

SENSEX

2%

0.1%

8.6%


You may also like the below Video Courses